Sort
39,280 grants matching “leukemia”
Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing
$514,090Bingliang Fang · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
CAREER: Novel expansion strategies for biomanufacturing of natural killer cells
$514,082Samira M Azarin · University Of Minnesota-Twin Cities · · FY2019 · ENG
Eltrombopag for bone marrow failure and Diamond-Blackfan Anemia
$514,058Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Animal models to study the role of INK4b loss in human acute myeloid leukemia
$514,049Linda Wolff · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Dynamics of Tumor Stem Cells in Cancer Initiation, Therapy, and Resistance
$513,998Franziska Michor · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
Novel targeted therapy to reduce health disparities in pediatric leukemia
$513,972Sinisa Dovat · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · CA
Phase separation-induced nuclear organization in ALT Cancer
$513,961Huaiying Zhang · Carnegie-Mellon University · U01 · FY2024 · CA
Harnessing naturally occurring cell type-specific regulatory elements and normal HSC hematopoiesis to develop cell lineage-controlled CAR expression and continuously renewing CAR NK cells
$513,859Eric L Smith · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Harnessing naturally occurring cell type-specific regulatory elements and normal HSC hematopoiesis to develop cell lineage-controlled CAR expression and continuously renewing CAR NK cells
$513,859Eric L Smith · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Monitoring disease progression in follicular lymphoma with next-gen sequencing
$513,853Christopher S Carlson · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
ONCOGENESIS AND MYELOID TRANSCRIPTION FACTORS IN AML
$513,821Daniel G Tenen · Dana-Farber Cancer Inst · P01 · FY2008 · CA
Regulation of Mast Cell Proteases
$513,681Richard L Stevens · Brigham And Women'S Hospital · P01 · FY2009 · HL
Biofunctional Polymers for Intracellular Drug Delivery
$513,659Patrick S. Stayton · University Of Washington · R01 · FY2010 · EB
Arsenic Trioxide &Ascorbic Acid for Multiple Myeloma
$513,593University Of Miami School Of Medicine · R01 · FY2004 · CA
Small molecule CXCR4 modulators as molecular probes for studying AML
$513,581Gary E Schiltz · Northwestern University · R01 · FY2017 · CA
Tumor Microenvironment in Cancer Progression
$513,579Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Translational Pathology Core
$513,466William Dean Wallace · University Of Southern California · P30 · FY2024 · CA
Novel CART Cells for Treating AML
$513,445Xianxin Hua · University Of Pennsylvania · R01 · FY2023 · CA
Clinical Consortia (Pediatric & Adult)
$513,343Stephen E Sallan · Dana-Farber Cancer Inst · P01 · FY2010 · CA
Immune reconstitution following autologous and allogeneic stem cell transplant
$513,266Jeremy Rose · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
FANCONI ANEMIA GENE FUNCTION IN GENOME STABILITY AND TUMOR SUPPRESSION
$513,228Robb E Moses · Oregon Health & Science University · P01 · FY2008 · HL
Molecular Studies of Bone Marrow Failure
$513,180Washington University · R01 · FY2005 · CA
mRNA stability and its impact on hematopoiesis and acute leukemia
$513,127Iannis Aifantis · New York University School Of Medicine · R01 · FY2024 · CA
GP130/STAT3 signalling in articular cartilage development and regeneration
$513,114Denis Evseenko · University Of Southern California · R01 · FY2022 · AR
Hepatic Gene Transfer for Treatment of Hemophilias A&B
$513,056Mark A Kay · Stanford University · R01 · FY2008 · HL